Project Grant HT94252310295
Award Date
5/15/23
Completion Date
5/14/26
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
This $1,430,088 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of Pittsburgh on "ANDROGEN RECEPTOR NUCLEAR LOCALIZATION IN CASTRATION-RESISTANT PROSTATE CANCER". The research project, which runs from March 1, 2024 to February 28, 2027, aims to investigate the role of androgen receptor localization in prostate cancer that has become resistant to androgen deprivation therapy. As a...
The University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh, was awarded a $636,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on a novel combination therapy targeting growth factor receptor cross talk with epitranscriptomic regulation in glioblastoma, a type of brain cancer, with the goal of developing innovative medical...
The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The University of Pittsburgh received a $454,142.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "FERROPTOSIS AS A METABOLIC VULNERABILITY OF CYCLIN E-HIGH OVARIAN CANCER". This 2-year research project, with a performance period from May 2024 to May 2026, aims to investigate metabolic vulnerabilities in a specific type of ovarian cancer. The University of Pittsburgh is the primary...
The University of Pittsburgh was awarded a $925,680 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2023 to July 31, 2027 targeting the IGFBP2-SRC signaling axis to block metastatic spread and tumor-mesothelial crosstalk. Through this research, the University aims to develop medical solutions for the battlefield by investigating approaches to prevent cancer metastasis. The Military...
This $1,264,474 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of Pittsburgh's research on "Molecular Insights into Immune Suppression in Kidney Cancer and Novel Therapeutic Opportunities". The grant, effective September 1, 2024 through August 31, 2028, will fund the university's investigations into improving understanding of immune system mechanisms involved in kidney cancer and...
The University of Pittsburgh has been awarded a $1,541,823 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development federal grant program (CFDA 12.420) to develop fast treatment methods for metastatic cancer patients with pleural disease. The grant, which runs from November 1, 2024 to October 31, 2028, will fund the University's research efforts to explore innovative approaches to disease prevention, diagnosis, treatment, and management of these...
The University of Pittsburgh was awarded a $2,806,431.00 Project Grant on July 1, 2023 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to optimize small molecule therapeutics to treat focal segmental glomerulosclerosis. This basic, applied, and advanced biomedical research aims to transform health care by developing innovative and impactful medical solutions for Service Members and the American public. The University of Pittsburgh will...
The University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh, received a $724,997.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the project "RECOVERY OF TENDON INJURY BY TARGETING ITS ROOT CAUSE AND ENHANCING TENDON STEM CELLS." The grant period of performance is from July 1, 2023 to June 30, 2026. The project aims to conduct biomedical...
This $4,902,315 federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports the University of Pittsburgh's research to understand the effects of intracavitary conditioning in breast cancer metastatic to the pleura or the peritoneum. The research, which began on June 1, 2025 and is scheduled for completion by May 31, 2029, aims to advance medical solutions for service members and the public by investigating...